An ongoing dialogue on HIV/AIDS, infectious diseases,
May 4th, 2010
Zoster Vaccine Underutilized
From the Annals of Internal Medicine:
Eighty-eight percent of providers recommend herpes zoster vaccine and 41% strongly recommend it, compared with more than 90% who strongly recommend influenza and pneumococcal vaccines. For physicians in both specialties [Internal Medicine and Family Practice], the most frequently reported barriers to vaccination were financial.
From my admittedly biased perspective as an ID doctor, recommending the zoster vaccine is a no-brainer. The cases of zoster I see are severe, and complicated, and people with post-herpetic neuralgia (who sometimes find their way erroneously to our clinic) are miserable.
But I’m also biased in that I’m not in a private, independent practice, and hence not responsible for getting reimbursed for giving a vaccine with irregular insurance coverage and finicky storage requirements.
So my guess is that were the vaccine universally covered (i.e., “free”), that there would be much broader uptake.
After all, for most Americans over 60, which is more likely to prevent illness — the zoster vaccine or the tetanus booster?
Paul E. Sax, MD
Contributing Editor
NEJM Journal Watch
Infectious Diseases
Biography | Disclosures | Summaries
Learn more about HIV and ID Observations.
NEJM Journal Watch — Recent Infectious Disease Articles- Rising Rates of Perinatal HIV: Maryland, 2022
- Do Children Need a Booster of Typhoid Conjugate Vaccine?
- Infection with Tecovirimat-Resistant Mpox Virus Is on the Rise in the U.S.
- Kidney Transplantation: Offering HOPE for Those with HIV
- Observations from ID and Beyond: Brave New Name — How PCP Became PJP and Why It Matters